US 12,258,638 B2
Airborne pathogen simulants and mobility testing
Ulrike W. Hodges, Berkeley, CA (US); Quin Chou, Pleasanton, CA (US); Erik Malmstrom, San Jose, CA (US); and Phil M. Arnold, Redwood City, CA (US)
Assigned to SafeTraces, Inc., Pleasanton, CA (US)
Filed by SafeTraces, Inc., Pleasanton, CA (US)
Filed on Feb. 2, 2021, as Appl. No. 17/165,935.
Claims priority of provisional application 63/066,076, filed on Aug. 14, 2020.
Claims priority of provisional application 63/011,176, filed on Apr. 16, 2020.
Prior Publication US 2021/0324485 A1, Oct. 21, 2021
Int. Cl. C12Q 1/70 (2006.01); C12Q 1/68 (2018.01); C12Q 1/6825 (2018.01); C12Q 1/6851 (2018.01); C12Q 1/686 (2018.01)
CPC C12Q 1/701 (2013.01) [C12Q 1/68 (2013.01); C12Q 1/6825 (2013.01); C12Q 1/6851 (2013.01); C12Q 1/686 (2013.01)] 23 Claims
OG exemplary drawing
 
1. A method of distributing a saliva simulant, comprising:
receiving the saliva simulant, wherein the saliva simulant comprises water, a DNA taggant, and a carrier, and wherein the saliva simulant simulates human emission of a target pathogen;
spraying the saliva simulant in air at a first release location in a determined release amount, to be detected at a first collection location, wherein a detected amount of the saliva simulant detected at the first collection location relative to the determined release amount is indicative of a degree of airflow from the first release location to the first collection location;
collecting a sample at the first collection location;
determining a tracer concentration at the first collection location based on the detected amount of the saliva simulant detected at the first collection location;
determining a scale that correlates tracer concentrations to inhalation probabilities and/or viral load;
based on the collected amount and/or the tracer concentration, and based on the scale, determining an infection risk value representing infection risk in an enclosed space diagnostic of infection by the target pathogen; and
generating a report displaying a first graphic element representing the infection risk value and displaying a second graphic element representing the detected amount of the saliva simulant at the first collection location in a map comprising the first release location and the first collection location.